definiens: ) . As used herein means curren t Good Manufacturing Practices pursuant to ( a ) the U.S. Fe deral Food, Drug and Cosmetics Act as amended ( 21 U SC 301 et seq . ), ( b ) relevant U.S. regulations found i n Title 21 of the U.S. Code of Federal Regulations ( including but not limited to Parts 11, 210, 211, 600 and 611 ), ( c ) EEC Directive 91/356 / EEC of 13 June 1991, ( d ) the Canadian Food and Drugs Act, Part C ( drugs ) and Goo d Manufacturing Practice Guidelines and ( e ) the EC Guide to Good Manufacturing Practice for Medicinal Drug Products, including respective guidance docume nts and any comparable laws, rules or regulations of an y agreed upon foreign jurisdiction, as each may be amended from time to time . cGMP also includes adherence to any applicable Product license requirements, releva nt current International Conference on Harmonization ( ICH ) guidance documents, and other relevant guidanc e documents